Sphingosine 1-phosphate induces Ca2+ transients and cytoskeletal rearrangement in C2C12 myoblastic cells

Am J Physiol Cell Physiol. 2002 Jun;282(6):C1361-73. doi: 10.1152/ajpcell.00378.2001.

Abstract

In many cell systems, sphingosine 1-phosphate (SPP) increases cytosolic Ca2+ concentration ([Ca2+]i) by acting as intracellular mediator and extracellular ligand. We recently demonstrated (Meacci E, Cencetti F, Formigli L, Squecco R, Donati C, Tiribilli B, Quercioli F, Zecchi-Orlandini S, Francini F, and Bruni P. Biochem J 362: 349-357, 2002) involvement of endothelial differentiation gene (Edg) receptors (Rs) specific for SPP in agonist-mediated Ca2+ response of a mouse skeletal myoblastic (C2C12) cell line. Here, we investigated the Ca2+ sources of SPP-mediated Ca2+ transients in C2C12 cells and the possible correlation of ion response to cytoskeletal rearrangement. Confocal fluorescence imaging of C2C12 cells preloaded with Ca2+ dye fluo 3 revealed that SPP elicited a transient Ca2+ increase propagating as a wave throughout the cell. This response required extracellular and intracellular Ca2+ pool mobilization. Indeed, it was significantly reduced by removal of external Ca2+, pretreatment with nifedipine (blocker of L-type plasma membrane Ca2+ channels), and inositol 1,4,5-trisphosphate [Ins(1,4,5)P3]-mediated Ca2+ pathway inhibitors. Involvement of EdgRs was tested with suramin (specific inhibitor of Edg-3). Fluorescence associated with Ins(1,4,5)P3Rs and L-type Ca2+ channels was evident in C2C12 cells. SPP also induced C2C12 cell contraction. This event, however, was unrelated to [Ca2+]i increase, because the two phenomena were temporally shifted. We propose that SPP may promote C2C12 cell contraction through Ca2+-independent mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aniline Compounds
  • Animals
  • Caffeine / pharmacology
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling / drug effects*
  • Calcium Signaling / physiology
  • Cell Line
  • Cytoskeleton / drug effects*
  • Cytoskeleton / metabolism
  • Cytoskeleton / ultrastructure
  • DNA-Binding Proteins / antagonists & inhibitors
  • Diglycerides / biosynthesis
  • Extracellular Space / metabolism
  • Fluorescent Dyes
  • I-kappa B Proteins*
  • Inositol 1,4,5-Trisphosphate / biosynthesis
  • Inositol 1,4,5-Trisphosphate / pharmacology
  • Intracellular Fluid / metabolism
  • Lysophospholipids*
  • Mice
  • Microscopy, Confocal
  • Muscle Contraction / drug effects
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • NF-KappaB Inhibitor alpha
  • Potassium / pharmacology
  • Receptors, Lysophospholipid
  • Ryanodine Receptor Calcium Release Channel / drug effects
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology*
  • Suramin / pharmacology
  • Xanthenes

Substances

  • Aniline Compounds
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • DNA-Binding Proteins
  • Diglycerides
  • Fluorescent Dyes
  • I-kappa B Proteins
  • Lysophospholipids
  • Nfkbia protein, mouse
  • Receptors, Lysophospholipid
  • Ryanodine Receptor Calcium Release Channel
  • Xanthenes
  • NF-KappaB Inhibitor alpha
  • Fluo-3
  • sphingosine 1-phosphate
  • Caffeine
  • Suramin
  • Inositol 1,4,5-Trisphosphate
  • Sphingosine
  • Potassium
  • Calcium

Grants and funding